PL2120958T3 - Inhibitor stat3 posiadający właściwości przeciwnowotworowe i powiązane sposoby - Google Patents

Inhibitor stat3 posiadający właściwości przeciwnowotworowe i powiązane sposoby

Info

Publication number
PL2120958T3
PL2120958T3 PL07868993T PL07868993T PL2120958T3 PL 2120958 T3 PL2120958 T3 PL 2120958T3 PL 07868993 T PL07868993 T PL 07868993T PL 07868993 T PL07868993 T PL 07868993T PL 2120958 T3 PL2120958 T3 PL 2120958T3
Authority
PL
Poland
Prior art keywords
associated methods
cancer activity
stat3 inhibitor
stat3
inhibitor
Prior art date
Application number
PL07868993T
Other languages
English (en)
Inventor
James Turkson
Andrew D Hamilton
Richard Jove
Said M Sebti
Original Assignee
Univ Central Florida Res Found Inc
Univ Yale
Univ South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Central Florida Res Found Inc, Univ Yale, Univ South Florida filed Critical Univ Central Florida Res Found Inc
Publication of PL2120958T3 publication Critical patent/PL2120958T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07868993T 2006-12-06 2007-12-05 Inhibitor stat3 posiadający właściwości przeciwnowotworowe i powiązane sposoby PL2120958T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86879406P 2006-12-06 2006-12-06
PCT/US2007/086453 WO2008070697A2 (en) 2006-12-06 2007-12-05 Stat3 inhibitor having anti-cancer activity and associated methods
EP07868993.2A EP2120958B8 (en) 2006-12-06 2007-12-05 Stat3 inhibitor having anti-cancer activity and associated methods

Publications (1)

Publication Number Publication Date
PL2120958T3 true PL2120958T3 (pl) 2013-10-31

Family

ID=39493046

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07868993T PL2120958T3 (pl) 2006-12-06 2007-12-05 Inhibitor stat3 posiadający właściwości przeciwnowotworowe i powiązane sposoby

Country Status (6)

Country Link
US (1) US8609639B2 (pl)
EP (1) EP2120958B8 (pl)
CA (1) CA2671121C (pl)
DK (1) DK2120958T3 (pl)
PL (1) PL2120958T3 (pl)
WO (1) WO2008070697A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2671121C (en) 2006-12-06 2016-06-07 University Of Central Florida Research Foundation, Inc. Stat3 inhibitor having anti-cancer activity and associated methods
CA2737360A1 (en) * 2008-09-17 2010-03-25 University Of Central Florida Research Foundation, Inc. Inhibitors of stat3
US9022631B2 (en) 2012-06-13 2015-05-05 Innotec Corp. Flexible light pipe
US11406707B2 (en) 2014-02-10 2022-08-09 H. Lee Moffitt Cancer Center And Research Institute, Inc. STAT3 phosphorylation during graft-versus-host disease
WO2015164870A1 (en) 2014-04-25 2015-10-29 H. Lee Moffitt Cancer Center And Research Institute, Inc. Gamma-aa-peptide stat3/dna inhibitors and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008535785A (ja) 2005-02-25 2008-09-04 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン Ｓｔａｔ３の小分子阻害剤およびその使用
EP2010528B1 (en) * 2006-04-19 2017-10-04 Novartis AG 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling
CA2671121C (en) 2006-12-06 2016-06-07 University Of Central Florida Research Foundation, Inc. Stat3 inhibitor having anti-cancer activity and associated methods

Also Published As

Publication number Publication date
WO2008070697A3 (en) 2008-11-27
EP2120958A4 (en) 2011-11-09
US8609639B2 (en) 2013-12-17
WO2008070697A4 (en) 2009-01-22
CA2671121C (en) 2016-06-07
WO2008070697A2 (en) 2008-06-12
CA2671121A1 (en) 2008-06-12
EP2120958A2 (en) 2009-11-25
DK2120958T3 (da) 2013-07-01
EP2120958B1 (en) 2013-03-20
EP2120958B8 (en) 2013-05-15
US20110124602A1 (en) 2011-05-26

Similar Documents

Publication Publication Date Title
HUS2200052I1 (hu) Imidazotriazinok és imidazopirimidinek mint kinázgátlók
EP2035005A4 (en) THERAPY BASED ON CYTOKINE INHIBITORS
EP2057171A4 (en) GLYCOSIDASE SELECTIVE INHIBITORS AND USES THEREOF
EP2214669A4 (en) cytokine inhibitors
EP2200977A4 (en) F1F0-ATPASE INHIBITOR AND ASSOCIATED METHODS
HK1140616A1 (en) Pich-hs timing and operation pich-hs
PL2117521T3 (pl) Transdermalne systemy dostarczania zawierające bupiwakainę
ZA200901874B (en) Stat3/5 activation inhibitor
ZA200709854B (en) 17ß-HSD1 and STS inhibitors
EP2321289A4 (en) GLYCOSIDASE SELECTIVE INHIBITORS AND USES THEREOF
IL247957A0 (en) Anti-ephrinb2 antibodies and methods of using them
HK1137756A1 (en) Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors hif--4-
EP2373658A4 (en) STAT3 INHIBITORS AND THERAPEUTIC METHODS USING THE SAME
PL2120958T3 (pl) Inhibitor stat3 posiadający właściwości przeciwnowotworowe i powiązane sposoby
IL199427A (en) Radiation-protective compounds and related methods
EP2020167A4 (en) GENERIC SYSTEMS AND METHODS FOR ANTI-ELECTROMAGNETIC SHIELDING
EP2028971A4 (en) WORK AREA
GB0610059D0 (en) Uses and methods
GB0609094D0 (en) Steel set chair
GB0621665D0 (en) Blogmail and podmail
GB0606794D0 (en) Methods and uses
ZA200609603B (en) Shim